Get the Stockscreener App
0.00
100.00%
-7.59
Trxade Health Inc Stock (MEDS) Forecast
The Trxade Health Inc (MEDS) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $15.78, representing a + increase from the current price of $0.00. The highest analyst price target is $16.63, and the lowest is $14.92.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month MEDS Price Target
Average 18.61
(+ Upside)
Is Trxade Health Inc (MEDS) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 19.07 | Buy |
| STOCH(9,6) | 49.42 | Neutral |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | -0.968 | Sell |
| ADX(14) | 12.57 | Neutral |
| William %R | -100.00 | Buy |
| CCI(14) | -495.92 | Sell |
Buy: 2
Sell: 3
Neutral: 2
Summary: Sell
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
6.392
Sell
|
5.8903
Sell
|
| MA20 |
6.862
Sell
|
6.6971
Sell
|
| MA50 |
9.1184
Sell
|
8.1172
Sell
|
| MA100 |
8.9577
Sell
|
8.8234
Sell
|
| MA200 |
8.8112
Sell
|
8.6502
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, MEDS could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 13 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on MEDS, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 19.07 indicates that MEDS is oversold. This indicates that MEDS price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 49.42 indicates that MEDS is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that MEDS is oversold. This suggests that MEDS price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 12.57 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -495.92 indicates that MEDS is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term MEDS price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Trxade Health Inc financial reports and earnings history, Trxade Health Inc (MEDS) stock could reach $24.14 by 2030, $114.28 by 2040 and $173.06 by 2050. See the projected annual prices until 2050 of the Trxade Health Inc stock below:
- Trxade Health Inc (MEDS) is expected to reach an average price of $21.38 in 2035, with a high prediction of $21.45 and a low estimate of $19.82. This indicates an $ rise from the last recorded price of $0.00.
- Trxade Health Inc (MEDS) stock is projected to chart a bullish course in 2040, with an average price target of $21.90, representing an $ surge from its current level. The forecast ranges from a conservative $21.35 to a sky-high $114.28.
- Our analysts predict Trxade Health Inc (MEDS) to jump by 2045, soaring from $141.77 to an average price of $148.30, potentially reaching $152.12. While $141.77 is the low estimate, the potential upside is significant.
- Trxade Health Inc (MEDS) stock is expected to climb by 2050, reaching an average of $172.06, a $ jump from its current level. However, a wide range of estimates exists, with high and low targets of $173.06 and $171.14, respectively, highlighting the market's uncertainty.
Trxade Health Inc Stock (MEDS) Year by Year Forecast
Trxade Health Inc Stock (MEDS) Price Forecast for 2025
Trxade Health Inc Stock (MEDS) is expected to reach an average price of $18.57 in 2025, with a high prediction of $22.29 and a low estimate of $14.84. This indicates an + rise from the last recorded price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| February, 2025 | $16.43 | $14.92 | $16.63 | + |
| March, 2025 | $16.63 | $15.91 | $17.83 | + |
| April, 2025 | $17.58 | $15.87 | $18.76 | + |
| May, 2025 | $17.18 | $16.53 | $18.67 | + |
| June, 2025 | $16.72 | $16.51 | $17.84 | + |
| July, 2025 | $18.47 | $17.01 | $19.12 | + |
| August, 2025 | $17.53 | $16.50 | $20.59 | + |
| September, 2025 | $18.61 | $17.44 | $19.16 | + |
| October, 2025 | $19.71 | $18.59 | $20.08 | + |
| November, 2025 | $21.45 | $19.53 | $22.29 | + |
| December, 2025 | $21.36 | $19.75 | $22.20 | + |
Trxade Health Inc Stock (MEDS) Price Forecast for 2026
The predicted value for Trxade Health Inc (MEDS) in 2026 is set at an average of $23.06. Estimates vary from a peak of $27.15 to a trough of $18.98, indicating an + surge from the present price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $20.35 | $19.70 | $22.29 | + |
| February, 2026 | $19.51 | $19.49 | $20.78 | + |
| March, 2026 | $20.04 | $18.98 | $20.08 | + |
| April, 2026 | $23.28 | $20.18 | $27.15 | + |
| May, 2026 | $22.21 | $21.44 | $25.17 | + |
| June, 2026 | $22.78 | $22.10 | $23.08 | + |
| July, 2026 | $23.33 | $22.80 | $23.60 | + |
| August, 2026 | $23.23 | $23.23 | $23.54 | + |
| September, 2026 | $22.95 | $22.89 | $23.41 | + |
| October, 2026 | $22.70 | $22.27 | $23.17 | + |
| November, 2026 | $22.43 | $22.31 | $22.99 | + |
| December, 2026 | $22.71 | $22.19 | $22.90 | + |
Trxade Health Inc Stock (MEDS) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Trxade Health Inc (MEDS) is $24.92, with a high forecast of $27.18 and a low forecast of $22.67. This indicates an + increase from the last price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $22.96 | $22.67 | $23.18 | + |
| February, 2027 | $23.93 | $23.03 | $24.06 | + |
| March, 2027 | $24.10 | $23.96 | $25.23 | + |
| April, 2027 | $23.93 | $23.72 | $24.34 | + |
| May, 2027 | $24.66 | $24.14 | $24.82 | + |
| June, 2027 | $25.40 | $24.54 | $25.40 | + |
| July, 2027 | $25.71 | $25.26 | $25.85 | + |
| August, 2027 | $25.75 | $25.51 | $25.97 | + |
| September, 2027 | $26.29 | $25.86 | $26.55 | + |
| October, 2027 | $26.50 | $26.28 | $26.56 | + |
| November, 2027 | $26.70 | $26.61 | $26.85 | + |
| December, 2027 | $27.08 | $26.69 | $27.18 | + |
Trxade Health Inc Stock (MEDS) Price Forecast for 2028
In 2028, Trxade Health Inc (MEDS) is projected to reach an average price of $38.47, with a high projection of $49.84 and a low estimate of $27.10. This indicates an + rise from the last price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $27.49 | $27.10 | $27.88 | + |
| February, 2028 | $27.97 | $27.55 | $28.02 | + |
| March, 2028 | $28.51 | $27.96 | $28.57 | + |
| April, 2028 | $28.85 | $28.56 | $29.09 | + |
| May, 2028 | $29.50 | $28.92 | $29.50 | + |
| June, 2028 | $29.85 | $29.59 | $29.86 | + |
| July, 2028 | $38.47 | $29.99 | $41.57 | + |
| August, 2028 | $37.94 | $37.87 | $49.84 | + |
| September, 2028 | $38.28 | $37.05 | $44.26 | + |
| October, 2028 | $43.44 | $37.57 | $45.75 | + |
| November, 2028 | $39.03 | $37.95 | $43.15 | + |
| December, 2028 | $38.50 | $37.81 | $40.08 | + |
Trxade Health Inc Stock (MEDS) Price Forecast for 2029
The 2029 price forecast for Trxade Health Inc Stock (MEDS) is $45.33 on average, with a high prediction of $79.57 and a low estimate of $11.10. This represents an + increase from the previous price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $39.05 | $37.73 | $39.14 | + |
| February, 2029 | $38.73 | $38.17 | $39.71 | + |
| March, 2029 | $38.39 | $37.80 | $39.38 | + |
| April, 2029 | $39.03 | $38.02 | $39.90 | + |
| May, 2029 | $63.81 | $42.15 | $79.57 | + |
| June, 2029 | $42.77 | $42.70 | $62.70 | + |
| July, 2029 | $42.38 | $41.51 | $43.25 | + |
| August, 2029 | $12.36 | $11.10 | $12.46 | + |
| September, 2029 | $13.16 | $12.28 | $13.54 | + |
| October, 2029 | $14.26 | $13.19 | $14.26 | + |
| November, 2029 | $15.35 | $14.49 | $15.45 | + |
| December, 2029 | $16.25 | $15.57 | $16.25 | + |
Trxade Health Inc Stock (MEDS) Price Forecast for 2030
Trxade Health Inc Stock (MEDS) is expected to reach an average price of $24.81 in 2030, with a high forecast of $33.30 and a low forecast of $16.33. This signifies an + surge from the last price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $21.14 | $16.33 | $24.14 | + |
| February, 2030 | $22.79 | $20.37 | $28.41 | + |
| March, 2030 | $24.15 | $22.87 | $24.97 | + |
| April, 2030 | $24.90 | $24.16 | $26.78 | + |
| May, 2030 | $25.94 | $24.58 | $26.90 | + |
| June, 2030 | $26.55 | $26.02 | $28.16 | + |
| July, 2030 | $28.07 | $26.43 | $29.68 | + |
| August, 2030 | $28.59 | $27.66 | $28.78 | + |
| September, 2030 | $30.08 | $28.32 | $30.21 | + |
| October, 2030 | $29.14 | $28.98 | $32.27 | + |
| November, 2030 | $30.87 | $29.26 | $33.30 | + |
| December, 2030 | $32.09 | $30.94 | $32.44 | + |
2.54%
0.73%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):